Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.
Fine
B M
BM
Genentech, Inc., South San Francisco, California, USA. bfine@gene.com
Amler
L
L
D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor; D016503:Drug Delivery Systems; D015195:Drug Design; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors